Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C
- PMID: 23924495
- DOI: 10.1016/s1499-3872(13)60059-4
Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C
Abstract
Background: Liver steatosis and iron overload, which are frequently observed in chronic hepatitis C (CHC), may contribute to the progression of liver injury. This study aimed to evaluate the correlation between liver steatosis and iron overload in Polish patients with CHC compared to non-alcoholic fatty liver disease (NAFLD) and HFE-hereditary hemochromatosis (HH) patients.
Methods: A total of 191 CHC patients were compared with 67 NAFLD and 21 HH patients. Liver function tests, serum markers of iron metabolism, cholesterol and triglycerides were assayed. The inflammatory activity, fibrosis, iron deposits and steatosis stages were assessed in liver specimens. HFE gene polymorphisms were investigated by PCR-RFLP.
Results: Liver steatosis was associated with obesity and diabetes mellitus. This disease was confirmed in 76/174 (44%) CHC patients, most of whom were infected with genotype 1. The average grade of steatosis was higher in NAFLD patients. CHC patients had significantly higher iron concentrations and transferrin saturations than NAFLD patients. Compared with CHC patients, HH patients had higher values of serum iron parameters and more intensive hepatocyte iron deposits without differences in the prevalence and intensity of liver steatosis. In the CHC group, lipids accumulation in hepatocytes was significantly associated with the presence of serum markers of iron overload. No correlation between the HFE gene polymorphism and liver steatosis in CHC patients was found.
Conclusions: Liver steatosis was diagnosed in nearly half of CHC patients, most of whom were infected with genotype 1. The intensity of steatosis was lower in CHC patients than that in NAFLD patients because of a less frequent diagnosis of metabolic syndrome. Only in CHC patients were biochemical markers of iron accumulation positively correlated with liver steatosis; these findings were independent of HFE gene mutations.
Similar articles
-
The role of iron overload and HFE gene mutations in the era of pegylated interferon and ribavirin treatment of chronic hepatitis C.Med Sci Monit. 2010 Mar;16(3):CR137-143. Med Sci Monit. 2010. PMID: 20190684 Clinical Trial.
-
Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan.World J Gastroenterol. 2005 Jul 7;11(25):3905-8. doi: 10.3748/wjg.v11.i25.3905. World J Gastroenterol. 2005. PMID: 15991291 Free PMC article.
-
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.World J Gastroenterol. 2012 Jun 14;18(22):2813-20. doi: 10.3748/wjg.v18.i22.2813. World J Gastroenterol. 2012. PMID: 22719190 Free PMC article.
-
Role of hemochromatosis genes in chronic hepatitis C.Clin Ter. 2006 Jan-Feb;157(1):61-8. Clin Ter. 2006. PMID: 16669553 Review.
-
[Involvement and role of iron in nonalcoholic steatohepatitis].Rev Med Chir Soc Med Nat Iasi. 2008 Apr-Jun;112(2):308-12. Rev Med Chir Soc Med Nat Iasi. 2008. PMID: 19294996 Review. Romanian.
Cited by
-
Low-Iron Diet-Induced Fatty Liver Development Is Microbiota Dependent and Exacerbated by Loss of the Mitochondrial Iron Importer Mitoferrin2.Nutrients. 2024 Jun 8;16(12):1804. doi: 10.3390/nu16121804. Nutrients. 2024. PMID: 38931165 Free PMC article.
-
Association between dietary iron intake and the prevalence of nonalcoholic fatty liver disease: A cross-sectional study.Medicine (Baltimore). 2019 Oct;98(43):e17613. doi: 10.1097/MD.0000000000017613. Medicine (Baltimore). 2019. PMID: 31651873 Free PMC article.
-
Dietary Iron Overload Differentially Modulates Chemically-Induced Liver Injury in Rats.Nutrients. 2020 Sep 11;12(9):2784. doi: 10.3390/nu12092784. Nutrients. 2020. PMID: 32932999 Free PMC article.
-
The Role of Iron and Iron Overload in Chronic Liver Disease.Med Sci Monit. 2016 Jun 22;22:2144-51. doi: 10.12659/msm.896494. Med Sci Monit. 2016. PMID: 27332079 Free PMC article. Review.
-
Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls.PLoS One. 2016 Sep 22;11(9):e0163423. doi: 10.1371/journal.pone.0163423. eCollection 2016. PLoS One. 2016. PMID: 27657935 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical